Squeeze
MPW- About TImeMPW has been taking its swwwweeeetttt time overlapping and making lower lows
This is absolutely related to that insane borrow fee and the shorting taking place
But as with everything else, all things must come to an end :)
Shorts are about to get wrecked for the next couple months most likely
This should fly right along with the other stuff that squeezes from now throughout the summer
I'll most likely end up making this part of my "Squeeze Me" series
SQUEEZE ME PART DEAUX- UpdateThe lines are when I expect these to Squeeze potentially
Like Gamestop, these are likely to run before then so be on the lookout for any sustained higher highs and higher lows as that may potentially be the "Sandworm" ala RK's tweets, starting for these particular stocks
Potential bottom, turnaround; catalyst today?Buenos dias,
This stock is crazy and I won't get into the details except at high level: The stock has, until recently, only had ~6.5m issued shares. Some dingus (or genius) cashed in their warrants for ~130m new shares, which sent the trade volume into a craze the past few days. Yesterday GCTK was the most traded stock and the most shorted stock on NASDAQ. Today the market cap of the company based on issued shares is approximately $ 20m. We do not know if the original owner of the warrants cashed out, is holding, or plans to cash out, although they received an outsized portion of shares for their warrants and could dump on the market, although I suspect the massive volume is related to their offloading of shares.
Take a look at the larger chart - it has been dump city for years. So goes the life of a R&D company with no products. The company, however, has developed a novel diabetic monitor that is implantable, lasts 2-3 years, and gives real-time accurate data. This is an order of magnitude more efficient and capable than the best version of implantable devices today. The predict $ 1B in revenue early on after product launch.
Today, they are presenting their latest trial data, presumably from their human subjects, at a major biotech conference at 12:30pm Eastern. This will be their first human-based data release.
Taking a look at the past few days on the chart, despite a flood of new shares and despite a flood of shorting, the price has effectively triple bottomed at $0.11 and has withstood the great flood.
I suspect that this is a new floor, and we will see a period of upward price movement, likely preceded by a large spike today due to speculators. I believe shorters are massively offside here, and there is opportunity to make a significant gain today and potentially over the next few years. Once they go to launch their product, it will be too late for speculators to make massive ROIs.
SQUEEZE ME PART DEAUXIn my weekend Gamestop update video I mentioned that although it may be poetic to some to think that a Gamestop short squeeze will cause the market to crash, rarely if ever is it one single event that causes a market to decline.
Rather it's the CUMULATIVE effect of multiple market participants "getting out over their skis" from a risk perspective that ultimately brings markets to their knees (from a catalyst perspective that is)
So watch me prove it.
After GME peaks on 06/09 we are going to look at these plays and see how things went
:)
I just created this $300 Million dollar push in the market $HOTHOops?
Stock doubled in minutes causing huge losses to shortsellers and awesome wins to everyone who bought because of my alert
Volume went from 100 million shares to 270 million shares, stock went from $1.70 to $3.80 both within an hour 🔥
We're just getting started, shortsellers we're coming for you in 2025!
Multi-Week Trendline Showing Strong Support
Look at this sexy chart. All of December GME has been hanging out in this upward channel. The bottom line has acted as support not 2 or 3 times, but EIGHT freakin times. Today was critical in my opinion if the trendline was going to remain strong, especially on a Friday given that max pain was sitting under the line at $30.
RSI has also had a support line around 50. We have bounced off that line yet again. Hopefully soon this is the last one.
Another thing to note is OBV which has been steadily climbing indicating that any pullback is just a distribution period before another leg up.
In my opinion, next week we should see GME test the top of that trendline around $40. If it rejects we may see it come down to test the trend line again around $33 or $34. But if it breaks, we could see this puppy FLY to the Fibonacci extension from the May squeeze. We would match that squeeze at $64.98 while the next (log) line is at $205!!
Lets get it!
$BTC Moment of Truth - Massive Move Ahead!This whole move up to $100k appears to be topped out and coming to the final squeeze.
Going to be a drastic move in either direction very soon.
CRYPTOCAP:BTC is either going to $115k or ~$85-90k.
My Spidey-senses lean towards the latter; Bull Trap.
Volume has been falling off a cliff during this rally, showing a strong case for a Bearish Divergence.
If that happens, expect a drastic sling-shot rebound, so get your bids in now.
I do expect a Santa Rally EOM.
Squeeze MeWe love short squeezes
They are all about timing but if you are fortunate enough you can make exponential gains
GME is set to make an exponentially higher move up in a squeeze type move
But so are a lot of tickers
No guarantee these will all squeeze of course but they definitely exhibit gamestop-like movements
We have been in and out of all of these and currently hold positions in several
NOT FINANCIAL ADVICE
BellRing Brands: Capitalizing on Health and Wellness GrowthBellRing Brands has broken out of a stage-one double-bottom base, signaling strong technical action and providing a compelling entry point. As a leading company in the health and wellness industry, BellRing Brands is well-positioned to benefit from the increasing demand for ready-to-drink protein shakes and nutrition bars. This breakout suggests a strong potential for further upside.
Technical Overview:
The stock has seen accumulation over the past several weeks, bouncing off the 21-day EMA and currently trading near highs. Using the IBD base pattern methodology, we aim for a 20% profit target , with an 8% stop loss to manage risk.
Profit Target: $75.96, reflecting a 20% gain from current levels.
Stop Loss: $58.65, which is approximately 8% below the entry point.
Squeeze Indicator:
The MTF Squeeze Analyzer confirms that a squeeze has fired on both the daily and weekly timeframes. This indicates that volatility is expanding, supporting further price acceleration and aligning with the breakout setup.
Momentum and Market Overview:
With the MTF SqzMom Indicator, we observe that momentum is in an uptrend for the 4H and higher time frames (W, 4D, and 2D).
The current RS Rating is 87, further confirming its relative strength in the market.
Final Thoughts:
BellRing Brands offers a strong opportunity for growth investors, driven by solid fundamentals and technical strength. The 20% target aligns with IBD’s proven methodology, while the tools provided by TradeVizion , including the Squeeze Analyzer and MTF sqzMom , provide additional layers of confirmation for timing and managing the trade.
Leverage the advanced insights from TradeVizion ’s to improve your trading strategies with clarity and confidence.
I think I got this...but I'm going against the dollar at low low
Asia Thursday and very little rest for the wicked. My attempt at doing something for a change different to trading and getting a life, I ended up mowing the back lawn.
Betting here against the USD, I could feel the squeeeze for a bit of love for the EURO.
I like this combo, unlike Gold they don't start betting against you, if you get direction right they may not give it to you straight away, but then ya see your account an hour or 2 later and they liked your work. Well that's what I tell myself. Theres less volume this time of day.
Last night or yesterday daytime NY, as am in Australia, after sqeezing a bit of profit out of those tight-ars*s over at the Gold & Silver show, I went across and took about 5 long positions with the Japanese Indices, they were down about 1.7%, I saw that the chart was good to go long, the rubber-band trade which is my go-to, it was a pleasure to trade with them, I guess I was one of the first to turn the trade around for them and they appreciated that, but it was all the other hands coming in Long after me. I might make a video for a bit of a laugh.
RXRX - BIOTECH SQUEEZE PLAY RXRX - Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel medicines.
Consolidating since April, look left and see the explosive moves.
Grab cheap long dated calls and wait for news to come out. Easy R/R. Calls swing 100% on small moves and I've got a good bit cheaply Jan 2025 calls. 9 & 10 dollar strikes.
Huge opportunity here to cash in on any news or favorable Earnings Report in a few days.
Short squeeze targets 10-12 dollars, manage your own risk. Will be dumping calls on impulsive move.
$6 looks to be a strong bottom here, under that for any time other than a flash sale, this trade is invalid, and I won't be holding any calls.
NOT INVESTMENT ADVICE. TRADE YOUR PLAN!
SPY/ES1! Flagging In Bullish Carryover Trend - Squeeze PosssibleCheck out the APEX FLAGGING formation in the SPY and ES chart; they are aligning perfectly.
If my analysis is correct, the SPY and ES should move into an upward price squeeze after the Flag Apex volatility period (roughly 20+ minutes) is complete.
That means the SPY and ES should move into a more defined upward price trend as we close out the day today - possibly carrying into tomorrow.
Get some.
#trading #research #investing #tradingalgos #tradingsignals #cycles #fibonacci #elliotwave #modelingsystems #stocks #bitcoin #btcusd #cryptos #spy #es #nq #gold
Thanksgiving Gifts for ALL - RXRX - BIOTECH SQUEEZE PLAYRecursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel medicines. Its Recursion operating system enables advanced machine learning approaches to reveal drug candidates, mechanisms of action, novel chemistry, and potential toxicity, with the eventual goal of decoding biology and advancing new therapeutics that radically improve people's lives.
Chart looks primed, bounced off 6 dollar range a few times and is peaking out of the downtrend. I fully expect to find support along that trendline and chop until news sends this thing flying.
Short squeeze potential here and fibs look like a big move could be in store before Thanksgiving which will line up with news around Earnings time.
Holding long dated calls and some shares.
Calls dated Jan 2025 or later. 8,9,10 strikes
Fibs for targets.
LFG!
MBLY 100% SHORT SQUEEZE MOVE INBOUND!!! SKILLING:US100 : NASDAQ:MBLY BUY THESIS: I LIKE THE STOCK! 🚀🌑
(MY MONEY IS WHERE MY MOUTH IS!)
15K SHARES💎👐
✅ Symmetrical Triangle breakout incoming
✅ MACD & Stochastic Curling Upward
✅ RSI Oversold to Higher Highs and up trending
✅ 34% SHORT VOLUME RATIO
✅ 17.39% SHORT-FLOAT
✅ $19 INTRINSIC VALUE (ANALYSIS BELOW)
✅ .48 PEG RATIO (>1 IS GOOD)
✅ 30%+ GROWTH (26FWD P/E)
✅ #MOASS
Not Financial Advice 🖖
Intel Corporation ($INTC) - Potential Squeeze After Rate CutIntel Corporation ( NASDAQ:INTC ) is setting up for an exciting squeeze potential following an anticipated rate cut. Here's why the technical landscape could be shaping up for a big move:
Fibonacci Support Holding Strong
The stock is currently holding well above the 0.786 Fibonacci retracement level, which is a critical area of support. Historically, holding this level is a strong indicator that a reversal could be imminent. A rate cut would provide a fundamental catalyst to accelerate a recovery from this level, as lower borrowing costs typically improve market sentiment, especially for large-cap tech stocks like Intel.
Worst-Case Scenario: Testing $13–$14 Support
While we are optimistic about the current setup, the worst-case scenario to watch for is a potential retest of the $13–$14 range. This level marks a significant historical support zone and, if touched, could provide a final flush-out of weak hands before the stock rebounds. Should this happen, it would likely signal a capitulation event, paving the way for long-term bulls to step back in at attractive prices.
Squeeze Potential and Rebound Targets
If Intel holds its current Fibonacci support, we could be setting up for a short squeeze driven by fresh liquidity entering the market post-rate cut. With technical and fundamental catalysts aligning, the stock has potential to rally toward the $40+ level over the medium term. This would mark a massive rebound, and a retest of previous highs would not be out of the question.
Key Levels to Watch
Immediate Support: 0.786 Fib level
Worst-Case Support: $13–$14
Upside Target: $40+